nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Eruption—Doxorubicin—bone cancer	0.00922	0.00933	CcSEcCtD
Glimepiride—Cerebrovascular accident—Cisplatin—bone cancer	0.00884	0.00895	CcSEcCtD
Glimepiride—Hyponatraemia—Cisplatin—bone cancer	0.0087	0.00881	CcSEcCtD
Glimepiride—Glipizide—CYP3A4—bone cancer	0.00801	0.672	CrCbGaD
Glimepiride—Speech disorder—Methotrexate—bone cancer	0.00762	0.00771	CcSEcCtD
Glimepiride—Sweating increased—Cisplatin—bone cancer	0.0073	0.00738	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Methotrexate—bone cancer	0.0072	0.00729	CcSEcCtD
Glimepiride—Delirium—Epirubicin—bone cancer	0.00713	0.00721	CcSEcCtD
Glimepiride—Pancytopenia—Cisplatin—bone cancer	0.00711	0.0072	CcSEcCtD
Glimepiride—Vasodilation—Epirubicin—bone cancer	0.00698	0.00706	CcSEcCtD
Glimepiride—Vasodilation procedure—Epirubicin—bone cancer	0.00698	0.00706	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Epirubicin—bone cancer	0.00674	0.00682	CcSEcCtD
Glimepiride—Vasculitis—Methotrexate—bone cancer	0.00671	0.00679	CcSEcCtD
Glimepiride—Nocturia—Epirubicin—bone cancer	0.00661	0.00669	CcSEcCtD
Glimepiride—Delirium—Doxorubicin—bone cancer	0.00659	0.00667	CcSEcCtD
Glimepiride—Vasodilation—Doxorubicin—bone cancer	0.00646	0.00653	CcSEcCtD
Glimepiride—Vasodilation procedure—Doxorubicin—bone cancer	0.00646	0.00653	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Doxorubicin—bone cancer	0.00624	0.00631	CcSEcCtD
Glimepiride—Aplastic anaemia—Methotrexate—bone cancer	0.00615	0.00622	CcSEcCtD
Glimepiride—Nocturia—Doxorubicin—bone cancer	0.00611	0.00619	CcSEcCtD
Glimepiride—Bradycardia—Cisplatin—bone cancer	0.0061	0.00618	CcSEcCtD
Glimepiride—Coma—Methotrexate—bone cancer	0.00599	0.00606	CcSEcCtD
Glimepiride—Visual impairment—Cisplatin—bone cancer	0.00578	0.00585	CcSEcCtD
Glimepiride—Aplastic anaemia—Epirubicin—bone cancer	0.00576	0.00583	CcSEcCtD
Glimepiride—Coma—Epirubicin—bone cancer	0.0056	0.00567	CcSEcCtD
Glimepiride—Diabetes mellitus—Methotrexate—bone cancer	0.00547	0.00553	CcSEcCtD
Glimepiride—Arrhythmia—Cisplatin—bone cancer	0.00536	0.00542	CcSEcCtD
Glimepiride—Aplastic anaemia—Doxorubicin—bone cancer	0.00533	0.00539	CcSEcCtD
Glimepiride—Mental disability—Epirubicin—bone cancer	0.00532	0.00538	CcSEcCtD
Glimepiride—Hepatic failure—Methotrexate—bone cancer	0.00529	0.00536	CcSEcCtD
Glimepiride—Erythema—Cisplatin—bone cancer	0.00522	0.00528	CcSEcCtD
Glimepiride—Malnutrition—Cisplatin—bone cancer	0.00522	0.00528	CcSEcCtD
Glimepiride—Coma—Doxorubicin—bone cancer	0.00518	0.00525	CcSEcCtD
Glimepiride—Diabetes mellitus—Epirubicin—bone cancer	0.00512	0.00518	CcSEcCtD
Glimepiride—Hepatic function abnormal—Epirubicin—bone cancer	0.00509	0.00515	CcSEcCtD
Glimepiride—Hepatic failure—Epirubicin—bone cancer	0.00495	0.00501	CcSEcCtD
Glimepiride—Mental disability—Doxorubicin—bone cancer	0.00492	0.00498	CcSEcCtD
Glimepiride—Vision blurred—Cisplatin—bone cancer	0.00492	0.00498	CcSEcCtD
Glimepiride—Tremor—Cisplatin—bone cancer	0.00489	0.00495	CcSEcCtD
Glimepiride—Cerebrovascular accident—Methotrexate—bone cancer	0.00485	0.00491	CcSEcCtD
Glimepiride—Anaemia—Cisplatin—bone cancer	0.00482	0.00488	CcSEcCtD
Glimepiride—Hot flush—Epirubicin—bone cancer	0.00476	0.00481	CcSEcCtD
Glimepiride—Increased appetite—Epirubicin—bone cancer	0.00474	0.00479	CcSEcCtD
Glimepiride—Diabetes mellitus—Doxorubicin—bone cancer	0.00473	0.00479	CcSEcCtD
Glimepiride—Menopausal symptoms—Epirubicin—bone cancer	0.00472	0.00477	CcSEcCtD
Glimepiride—Hepatic function abnormal—Doxorubicin—bone cancer	0.00471	0.00477	CcSEcCtD
Glimepiride—Leukopenia—Cisplatin—bone cancer	0.00467	0.00473	CcSEcCtD
Glimepiride—Dermatitis bullous—Epirubicin—bone cancer	0.00466	0.00471	CcSEcCtD
Glimepiride—Hepatic failure—Doxorubicin—bone cancer	0.00458	0.00464	CcSEcCtD
Glimepiride—Hypoglycaemia—Epirubicin—bone cancer	0.00456	0.00461	CcSEcCtD
Glimepiride—Cerebrovascular accident—Epirubicin—bone cancer	0.00454	0.0046	CcSEcCtD
Glimepiride—Convulsion—Cisplatin—bone cancer	0.00452	0.00458	CcSEcCtD
Glimepiride—Hyponatraemia—Epirubicin—bone cancer	0.00447	0.00452	CcSEcCtD
Glimepiride—Pain in extremity—Epirubicin—bone cancer	0.00445	0.0045	CcSEcCtD
Glimepiride—Anxiety—Cisplatin—bone cancer	0.00443	0.00448	CcSEcCtD
Glimepiride—Hot flush—Doxorubicin—bone cancer	0.0044	0.00445	CcSEcCtD
Glimepiride—Increased appetite—Doxorubicin—bone cancer	0.00438	0.00444	CcSEcCtD
Glimepiride—Menopausal symptoms—Doxorubicin—bone cancer	0.00436	0.00442	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—bone cancer	0.00431	0.00436	CcSEcCtD
Glimepiride—Anaphylactic shock—Cisplatin—bone cancer	0.00426	0.00431	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—bone cancer	0.00422	0.00427	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—bone cancer	0.0042	0.00425	CcSEcCtD
Glimepiride—Thrombocytopenia—Cisplatin—bone cancer	0.00417	0.00422	CcSEcCtD
Glimepiride—Tachycardia—Cisplatin—bone cancer	0.00416	0.00421	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—bone cancer	0.00413	0.00418	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—bone cancer	0.00412	0.00417	CcSEcCtD
Glimepiride—Hyperhidrosis—Cisplatin—bone cancer	0.00412	0.00417	CcSEcCtD
Glimepiride—Eosinophilia—Methotrexate—bone cancer	0.00407	0.00412	CcSEcCtD
Glimepiride—Anorexia—Cisplatin—bone cancer	0.00406	0.00411	CcSEcCtD
Glimepiride—Hypotension—Cisplatin—bone cancer	0.00398	0.00403	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00392	0.00397	CcSEcCtD
Glimepiride—Glyburide—CYP3A4—bone cancer	0.00391	0.328	CrCbGaD
Glimepiride—Pancytopenia—Methotrexate—bone cancer	0.0039	0.00395	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—bone cancer	0.00387	0.00392	CcSEcCtD
Glimepiride—Influenza—Epirubicin—bone cancer	0.00385	0.00389	CcSEcCtD
Glimepiride—Paraesthesia—Cisplatin—bone cancer	0.00382	0.00387	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—bone cancer	0.00381	0.00385	CcSEcCtD
Glimepiride—Dyspnoea—Cisplatin—bone cancer	0.0038	0.00384	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—bone cancer	0.00375	0.0038	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—bone cancer	0.00375	0.00379	CcSEcCtD
Glimepiride—Decreased appetite—Cisplatin—bone cancer	0.0037	0.00375	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Cisplatin—bone cancer	0.00368	0.00372	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—bone cancer	0.00366	0.00371	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—bone cancer	0.00365	0.0037	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00363	0.00368	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00363	0.00368	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—bone cancer	0.00358	0.00363	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—bone cancer	0.00356	0.0036	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—bone cancer	0.00355	0.0036	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—bone cancer	0.00352	0.00357	CcSEcCtD
Glimepiride—Sweating—Methotrexate—bone cancer	0.00351	0.00356	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—bone cancer	0.00351	0.00355	CcSEcCtD
Glimepiride—Feeling abnormal—Cisplatin—bone cancer	0.00351	0.00355	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—bone cancer	0.0035	0.00354	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—bone cancer	0.00347	0.00351	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—bone cancer	0.00343	0.00347	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—bone cancer	0.00342	0.00346	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.0034	0.00344	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—bone cancer	0.00338	0.00342	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—bone cancer	0.00334	0.00338	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—bone cancer	0.00329	0.00333	CcSEcCtD
Glimepiride—Sweating—Epirubicin—bone cancer	0.00329	0.00333	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—bone cancer	0.00329	0.00333	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—bone cancer	0.00325	0.00329	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—bone cancer	0.00324	0.00328	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—bone cancer	0.0032	0.00324	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—bone cancer	0.00317	0.00321	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—bone cancer	0.00317	0.00321	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00315	0.00318	CcSEcCtD
Glimepiride—Hypersensitivity—Cisplatin—bone cancer	0.00314	0.00318	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—bone cancer	0.00313	0.00317	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—bone cancer	0.00311	0.00315	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—bone cancer	0.00309	0.00313	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—bone cancer	0.00308	0.00312	CcSEcCtD
Glimepiride—Asthenia—Cisplatin—bone cancer	0.00306	0.00309	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—bone cancer	0.00304	0.00308	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—bone cancer	0.00297	0.003	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—bone cancer	0.00296	0.003	CcSEcCtD
Glimepiride—Diarrhoea—Cisplatin—bone cancer	0.00291	0.00295	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—bone cancer	0.00291	0.00295	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—bone cancer	0.0029	0.00293	CcSEcCtD
Glimepiride—Erythema—Methotrexate—bone cancer	0.00286	0.0029	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—bone cancer	0.00286	0.0029	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—bone cancer	0.00285	0.00288	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—bone cancer	0.00275	0.00278	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—bone cancer	0.00275	0.00278	CcSEcCtD
Glimepiride—Vomiting—Cisplatin—bone cancer	0.00271	0.00274	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—bone cancer	0.0027	0.00273	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—bone cancer	0.00269	0.00273	CcSEcCtD
Glimepiride—Rash—Cisplatin—bone cancer	0.00269	0.00272	CcSEcCtD
Glimepiride—Dermatitis—Cisplatin—bone cancer	0.00268	0.00272	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—bone cancer	0.00268	0.00271	CcSEcCtD
Glimepiride—Erythema—Epirubicin—bone cancer	0.00268	0.00271	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—bone cancer	0.00265	0.00268	CcSEcCtD
Glimepiride—Tension—Epirubicin—bone cancer	0.00263	0.00266	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—bone cancer	0.0026	0.00263	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—bone cancer	0.00256	0.00259	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—bone cancer	0.00254	0.00258	CcSEcCtD
Glimepiride—Nausea—Cisplatin—bone cancer	0.00253	0.00256	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—bone cancer	0.00253	0.00256	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—bone cancer	0.00248	0.00251	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—bone cancer	0.00248	0.00251	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—bone cancer	0.00248	0.00251	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—bone cancer	0.00248	0.00251	CcSEcCtD
Glimepiride—Agitation—Epirubicin—bone cancer	0.00246	0.00249	CcSEcCtD
Glimepiride—Tension—Doxorubicin—bone cancer	0.00243	0.00246	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—bone cancer	0.00241	0.00244	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—bone cancer	0.0024	0.00243	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—bone cancer	0.00237	0.0024	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—bone cancer	0.00236	0.00238	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—bone cancer	0.00236	0.00238	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—bone cancer	0.00234	0.00237	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—bone cancer	0.00234	0.00237	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—bone cancer	0.00232	0.00235	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—bone cancer	0.00231	0.00234	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—bone cancer	0.00229	0.00232	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—bone cancer	0.00229	0.00232	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—bone cancer	0.00228	0.00231	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—bone cancer	0.00227	0.0023	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—bone cancer	0.00226	0.00229	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—bone cancer	0.00223	0.00226	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—bone cancer	0.00223	0.00225	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—bone cancer	0.00222	0.00225	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—bone cancer	0.00221	0.00223	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—bone cancer	0.00219	0.00222	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—bone cancer	0.00219	0.00221	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—bone cancer	0.00218	0.00221	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—bone cancer	0.00218	0.00221	CcSEcCtD
Glimepiride—Shock—Epirubicin—bone cancer	0.00215	0.00218	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—bone cancer	0.00215	0.00217	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—bone cancer	0.00214	0.00217	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—bone cancer	0.00214	0.00217	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—bone cancer	0.00213	0.00216	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—bone cancer	0.00211	0.00214	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—bone cancer	0.00211	0.00214	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—bone cancer	0.0021	0.00213	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—bone cancer	0.0021	0.00212	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—bone cancer	0.00208	0.00211	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—bone cancer	0.00208	0.00211	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—bone cancer	0.00208	0.0021	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—bone cancer	0.00206	0.00209	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—bone cancer	0.00206	0.00208	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—bone cancer	0.00204	0.00207	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—bone cancer	0.00204	0.00207	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—bone cancer	0.00203	0.00206	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—bone cancer	0.00202	0.00205	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—bone cancer	0.00202	0.00204	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—bone cancer	0.00201	0.00204	CcSEcCtD
Glimepiride—Shock—Doxorubicin—bone cancer	0.00199	0.00202	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—bone cancer	0.00198	0.00201	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—bone cancer	0.00198	0.002	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—bone cancer	0.00198	0.002	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—bone cancer	0.00196	0.00199	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—bone cancer	0.00196	0.00198	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—bone cancer	0.00195	0.00197	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—bone cancer	0.00194	0.00197	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—bone cancer	0.00193	0.00195	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—bone cancer	0.00193	0.00195	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—bone cancer	0.00193	0.00195	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—bone cancer	0.00191	0.00193	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—bone cancer	0.0019	0.00192	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—bone cancer	0.00189	0.00191	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—bone cancer	0.00189	0.00191	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—bone cancer	0.00189	0.00191	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—bone cancer	0.00186	0.00188	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—bone cancer	0.00185	0.00187	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—bone cancer	0.00183	0.00185	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—bone cancer	0.00182	0.00184	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—bone cancer	0.0018	0.00183	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—bone cancer	0.0018	0.00182	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—bone cancer	0.00179	0.00181	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—bone cancer	0.00178	0.0018	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—bone cancer	0.00176	0.00178	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00175	0.00177	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—bone cancer	0.00174	0.00177	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—bone cancer	0.00174	0.00176	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—bone cancer	0.00173	0.00175	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—bone cancer	0.00172	0.00174	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—bone cancer	0.00168	0.0017	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—bone cancer	0.00167	0.00169	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—bone cancer	0.00165	0.00167	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—bone cancer	0.00165	0.00167	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—bone cancer	0.00161	0.00163	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—bone cancer	0.00161	0.00163	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—bone cancer	0.0016	0.00162	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—bone cancer	0.0016	0.00162	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—bone cancer	0.00157	0.00159	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—bone cancer	0.00155	0.00157	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—bone cancer	0.00155	0.00156	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—bone cancer	0.0015	0.00151	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—bone cancer	0.00149	0.00151	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—bone cancer	0.00149	0.0015	CcSEcCtD
Glimepiride—Rash—Methotrexate—bone cancer	0.00147	0.00149	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—bone cancer	0.00147	0.00149	CcSEcCtD
Glimepiride—Headache—Methotrexate—bone cancer	0.00146	0.00148	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—bone cancer	0.00145	0.00147	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—bone cancer	0.00145	0.00146	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—bone cancer	0.00143	0.00145	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—bone cancer	0.00139	0.00141	CcSEcCtD
Glimepiride—Nausea—Methotrexate—bone cancer	0.00139	0.0014	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Glimepiride—Rash—Epirubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Glimepiride—Headache—Epirubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—bone cancer	0.00134	0.00135	CcSEcCtD
Glimepiride—Nausea—Epirubicin—bone cancer	0.0013	0.00131	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—bone cancer	0.00129	0.0013	CcSEcCtD
Glimepiride—Rash—Doxorubicin—bone cancer	0.00128	0.00129	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—bone cancer	0.00127	0.00129	CcSEcCtD
Glimepiride—Headache—Doxorubicin—bone cancer	0.00127	0.00128	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—bone cancer	0.0012	0.00122	CcSEcCtD
